Akebia Therapeutics | AKBA - Equity Capital And Reserves


Akebia Therapeutics reported $27.38M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 1.25B 20.68M Mar/2026
Agios Pharmaceuticals USD 1.03B 83.09M Jun/2026
Akebia Therapeutics USD 27.38M 5.24M Mar/2026
Alnylam Pharmaceuticals USD 1.35B 278.74M Jun/2026
Amgen USD 9.19B 532M Mar/2026
Ardelyx USD 148.62M 18.33M Mar/2026
Astellas Pharma JPY 1.83T 65.92B Mar/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Bayer EUR 28.85B 2.9B Mar/2026
BioMarin Pharmaceutical USD 6.21B 125.11M Mar/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Exelixis USD 1.94B 225.57M Mar/2026
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
Ironwood Pharmaceuticals USD -217.14M 44.69M Mar/2026
J&J USD 84.97B 3.78B Jun/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Karyopharm Therapeutics USD -292.93M 23.67M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Lexicon Pharmaceuticals USD 202.86M 95.32M Mar/2026
Medical Developments International AUD 54.77M 335K Dec/2025
Moderna USD 6.76B 647M Jun/2026
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 1.26M 7.41M Jun/2025
Pharma Mar EUR 250.77M 1.1M Jun/2026
Prothena USD 312.62M 32.14M Mar/2026
PTC Therapeutics USD -165.36M 15.1M Jun/2026
Qiagen NV USD 3.33B 446.45M Mar/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
Sarepta Therapeutics USD 1.51B 364.48M Mar/2026
Sartorius EUR 2.82B 96.3M Jun/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
Vanda Pharmaceuticals USD 327.19M 138.81M Dec/2025
Zealand Pharma A/S 14.47B 361.61M Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026